Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Agajanian
A Pivotal, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Phase 2 Study of Me-401 Investigating Two Dosing Schedules in Patients With Follicular Lymphoma (Fl) After Failure of Two or More Prior Systemic Therapies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports
Nephrology
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Tremelimumab for Second and Third Line Treatment in Patients With Unresectable Pleural or Peritoneal Mesothelioma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Immunome Research
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Propofol 2% in Two Different Oil-In-Water Emulsions: A Randomized, Double-Blind Study
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Effects of Fenofibrate on Albuminuria in Patients With Hypertriglyceridemia and/or Hyperuricemia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Current Therapeutic Research
Pharmacology
